Literature DB >> 17548683

Triallelic single nucleotide polymorphisms and genotyping error in genetic epidemiology studies: MDR1 (ABCB1) G2677/T/A as an example.

Claudia Hüebner1, Ivonne Petermann, Brian L Browning, Andrew N Shelling, Lynnette R Ferguson.   

Abstract

Accurate measurement of allele frequencies between population groups with differing sensitivities to disease is fundamental to genetic epidemiology. Genotyping errors can markedly influence the biological conclusions of a study. This issue may be especially important now there is increasing recognition of triallelic single nucleotide polymorphisms (SNPs) in the genome and their possible role in diseases like inflammatory bowel disease. For example, the MDR1 (ABCB1) SNP G2677/T/A was, like many other triallelic SNPs, originally described as diallelic. Here, we report a comprehensive analyses of estimated allele frequencies of this SNP in a set of 73 human DNA samples, comparing six commonly used genotyping methods (Applied Biosystems Taqman, Roche LightCycler melting analysis, allelic discrimination PCR, DNA sequencing, Sequenom, and RFLP) from the angle of their error potential. Only Sequenom and DNA sequencing provided accurate measurements, if we had not had prior knowledge of the triallelic nature of this SNP. The other tested methods (with the exception of LightCycler) failed to show any indication of the presence of the rare third A- allele in a diallelic assay. Although most of the errors were due to the inability to detect the third allele, all methods except Sequenom and sequencing produced errors for the detection of the two common alleles G and T (LightCycler, 6 errors; PCR, 4 errors; RFLP, 2 errors; Taqman, 1 error). There is considerable variability in the reported frequencies of the different alleles of the MDR1 G2677/T/A SNP, and the role of this SNP in the etiology of inflammatory bowel disease has been controversial. Our data emphasize the importance of choosing the appropriate method for SNP detection and lead us to suggest that part of the previously reported variation may reflect artifacts associated with the different genotyping methodologies used. The failure to recognize the triallic nature of a SNP may lead to underestimations of real genetic associations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17548683     DOI: 10.1158/1055-9965.EPI-06-0759

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  18 in total

1.  General triallelic frequency spectrum under demographic models with variable population size.

Authors:  Paul A Jenkins; Jonas W Mueller; Yun S Song
Journal:  Genetics       Date:  2013-11-08       Impact factor: 4.562

2.  Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.

Authors:  K van der Weide; H Loovers; K Pondman; J Bogers; T van der Straaten; E Langemeijer; D Cohen; J Commandeur; J van der Weide
Journal:  Pharmacogenomics J       Date:  2016-05-10       Impact factor: 3.550

3.  An extended IUPAC nomenclature code for polymorphic nucleic acids.

Authors:  Andrew D Johnson
Journal:  Bioinformatics       Date:  2010-03-03       Impact factor: 6.937

4.  Characterization of leptin receptor gene in Bubalus bubalis and association analysis with body measurement traits.

Authors:  Giovanna De Matteis; Maria Carmela Scatà; Gennaro Catillo; Giuseppina Maria Terzano; Francesco Grandoni; Francesco Napolitano
Journal:  Mol Biol Rep       Date:  2014-11-28       Impact factor: 2.316

5.  Genetic variations and patient-reported quality of life among patients with lung cancer.

Authors:  Jeff A Sloan; Mariza de Andrade; Paul Decker; Jason Wampfler; Curtis Oswold; Matthew Clark; Ping Yang
Journal:  J Clin Oncol       Date:  2012-03-26       Impact factor: 44.544

6.  Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy.

Authors:  L Knez; M Košnik; T Ovčariček; A Sadikov; E Sodja; I Kern; T Cufer
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-29       Impact factor: 4.553

7.  Genetic analysis of cytomegalovirus in malignant gliomas.

Authors:  Bornali Bhattacharjee; Nicholas Renzette; Timothy F Kowalik
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

8.  Genotyping error detection in samples of unrelated individuals without replicate genotyping.

Authors:  Nianjun Liu; Dabao Zhang; Hongyu Zhao
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

9.  Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes.

Authors:  Mirjam A G Sprangers; Jeff A Sloan; Andrea Barsevick; Cynthia Chauhan; Amylou C Dueck; Hein Raat; Quiling Shi; Cornelis J F Van Noorden
Journal:  Qual Life Res       Date:  2010-10-14       Impact factor: 4.147

Review 10.  Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine.

Authors:  Demissie Alemayehu; Joseph C Cappelleri
Journal:  Am Health Drug Benefits       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.